http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-94010496-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79013bcdaeb2567a3faef675c487bbd6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
filingDate 1994-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_496f0d43d8498d4a51021be25008e668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2420c0b35210779faf71753af3129c89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18049d47b12dc0e203b29544b246f001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9acf375bcb645157c6674e73ecc9b25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c597b23df7df36bd9c6dfb229c1b9545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1a43ec6ee8a3e753e487f8adaafe056
publicationDate 1997-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-94010496-A
titleOfInvention Nootropic agent and medicinal composition of nootropic agent
abstract The invention is used in medicine. The inventive use of the heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro as a nootropic agent. A new composition of a nootropic agent is proposed, containing the active substance in the form of a heptapeptide (0.95-1.05 g / l), a preservative in the form of nipagin (0.95-1.05 g / l), and the rest is distilled water. The composition is highly effective in low doses and easy to use: used in the form of drops in the nose.
priorityDate 1994-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523167

Total number of triples: 17.